• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用EMA-CO方案成功治愈部分性葡萄胎后持续性滋养细胞疾病。

Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.

作者信息

Dgani R, Zalel Y, Biran H, Blickstein I, Caspi B, Weissman A, Shoham Z

机构信息

Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.

出版信息

Eur J Obstet Gynecol Reprod Biol. 1994 Mar 31;54(1):77-9. doi: 10.1016/0028-2243(94)90084-1.

DOI:10.1016/0028-2243(94)90084-1
PMID:7519153
Abstract

A 29-year-old nullipara with partial hydatidiform mole at 8 weeks had pre-evacuation hCG levels of 275,000 mIU/ml. Free beta-hCG levels were measured as 3% (normal value below 4%). The patient developed persistent gestational trophoblastic disease, failed to respond to methotrexate and actinomycin D, but has responded to combination chemotherapy with EMA-CO. Such a response to EMA-CO was not reported previously.

摘要

一名29岁未生育女性,孕8周时诊断为部分性葡萄胎,清宫术前血hCG水平为275,000 mIU/ml。游离β-hCG水平测定为3%(正常值低于4%)。该患者发生持续性妊娠滋养细胞疾病,对甲氨蝶呤和放线菌素D治疗无效,但对EMA-CO联合化疗有反应。此前未见对EMA-CO如此反应的报道。

相似文献

1
Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.采用EMA-CO方案成功治愈部分性葡萄胎后持续性滋养细胞疾病。
Eur J Obstet Gynecol Reprod Biol. 1994 Mar 31;54(1):77-9. doi: 10.1016/0028-2243(94)90084-1.
2
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.对于对EMA/环磷酰胺和长春新碱化疗难治的高危妊娠滋养细胞肿瘤患者以及出现转移性胎盘部位滋养细胞肿瘤的患者,采用依托泊苷和顺铂/依托泊苷、甲氨蝶呤及放线菌素D(EMA)化疗。
J Clin Oncol. 2000 Feb;18(4):854-9. doi: 10.1200/JCO.2000.18.4.854.
3
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.低风险持续性妊娠滋养细胞疾病:1992年至2000年低剂量甲氨蝶呤和亚叶酸初始治疗后的结局
J Clin Oncol. 2002 Apr 1;20(7):1838-44. doi: 10.1200/JCO.2002.07.166.
4
Gestational trophoblastic disease.妊娠滋养细胞疾病
Curr Ther Endocrinol Metab. 1994;5:567-70.
5
Recurrent gestational trophoblastic disease following in-vitro fertilization.
Hum Reprod. 1994 Nov;9(11):2010-3. doi: 10.1093/oxfordjournals.humrep.a138384.
6
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?对于葡萄胎患者,在子宫排空后6个月血清人绒毛膜促性腺激素水平升高但呈下降趋势,是否需要进行化疗?
Gynecol Oncol. 2016 Dec;143(3):558-564. doi: 10.1016/j.ygyno.2016.09.012.
7
Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.接受依托泊苷、甲氨蝶呤、放线菌素、环磷酰胺和长春新碱(EMA-CO)化疗的滋养细胞肿瘤患者的血浆甲氨蝶呤水平。
Gynecol Oncol. 1993 Sep;50(3):300-4. doi: 10.1006/gyno.1993.1215.
8
Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.以部分性葡萄胎为前次妊娠的持续性妊娠滋养细胞肿瘤。
Br J Obstet Gynaecol. 1994 Apr;101(4):330-4. doi: 10.1111/j.1471-0528.1994.tb13620.x.
9
Invasive mole.侵蚀性葡萄胎
Eur J Obstet Gynecol Reprod Biol. 1986 Mar;21(3):181-5. doi: 10.1016/0028-2243(86)90034-1.
10
Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Gynecol Oncol. 1984 Mar;17(3):386-93. doi: 10.1016/0090-8258(84)90226-9.